Bioidentical vs. Conventional HRT: What Is the Difference?
The bioidentical HRT debate generates a lot of marketing and a lot of confusion. Some of the distinctions matter clinically. Most of the marketing does not. Here is what the evidence actually shows and what questions are worth asking your provider.
The Distinction That Actually Matters
The clinically meaningful distinction is not bioidentical vs. conventional. It is between specific types of hormones — particularly progesterone type.
The 2002 Women's Health Initiative study that scared a generation away from HRT used conjugated equine estrogen (derived from horse urine) plus synthetic medroxyprogesterone acetate. Subsequent research has shown that medroxyprogesterone acetate and other synthetic progestins carry a less favorable breast cancer risk profile than micronized progesterone — which is bioidentical and also FDA-approved (sold as Prometrium).
This is not a compounded vs. commercial distinction. FDA-approved micronized progesterone is available at any pharmacy. The question is whether your provider is prescribing micronized progesterone or a synthetic progestin — and if synthetic, why.
FDA-Approved Bioidentical Options
These are available at standard pharmacies without compounding:
Estradiol patches — Vivelle-Dot, Climara, Minivelle
Transdermal delivery — avoids first-pass liver metabolism. No increased blood clot risk the way oral estrogen carries.
Estradiol gels — Divigel, EstroGel
Applied daily to skin. Same transdermal benefit as patches. Some women prefer gels over patches for skin tolerance.
Estradiol sprays — Evamist
Sprayed on inner forearm. Transdermal, fast-drying.
Micronized progesterone — Prometrium
Oral (or can be used vaginally). More favorable breast cancer risk profile than synthetic progestins. The preferred progesterone for most menopause providers following current evidence.
Estradiol vaginal products — Vagifem, Imvexxy, Estring
Local delivery — minimal systemic absorption. Used specifically for genitourinary syndrome of menopause (vaginal dryness, pain with sex, urinary symptoms).
When Is Compounding Appropriate?
Compounded hormones have legitimate uses — they are not inherently bad, just less regulated. Situations where compounding may make sense:
- •A patient needs a delivery route or formulation not available commercially (e.g., a specific cream concentration)
- •Allergy to a component in commercial formulations
- •Dose needs that fall outside standard commercial options
- •Testosterone for women (no FDA-approved testosterone product for women exists — compounding is the only option)
The Menopause Society recommends FDA-approved options as the first line for most patients and reserves compounding for cases where commercial options are inadequate. Compounded hormones are not inherently safer — they have less oversight, not more.
Questions to Ask Your Provider
"Are you prescribing micronized progesterone or a synthetic progestin?"
This is the most clinically meaningful question in the progesterone choice. Micronized progesterone (Prometrium) has a more favorable breast cancer risk profile in the evidence. If synthetic progestin is recommended, ask why.
"Is this an FDA-approved formulation or a compounded one?"
You should know what you are taking. If compounded, ask why commercial options were not sufficient and what quality control the pharmacy uses.
"Are you using saliva testing to guide dosing?"
If yes, ask for the rationale. Saliva hormone levels are not validated for HRT dosing decisions — the Menopause Society does not endorse saliva testing for this purpose. Serum or dried blood spot testing are more reliable.
Find a menopause specialist who knows the current evidence
Providers with MSCP certification and documented HRT experience are more likely to have an informed conversation about these distinctions.
Bioidentical HRT FAQs
What does "bioidentical" actually mean?+
Bioidentical means the hormone is chemically identical to the hormone produced by the human body. Estradiol (the primary form of estrogen) and micronized progesterone (Prometrium) are bioidentical and are also FDA-approved medications. The term "bioidentical" is sometimes used specifically to mean compounded hormones — but FDA-approved bioidentical options exist and are often preferable to compounded versions for most patients because they have standardized dosing and quality control.
Is bioidentical HRT safer than conventional HRT?+
FDA-approved bioidentical hormones (estradiol + micronized progesterone) have a more favorable safety profile than the specific conventional formulations studied in the 2002 WHI study — which used conjugated equine estrogen plus synthetic medroxyprogesterone acetate. The meaningful distinction is between micronized progesterone and synthetic progestins: multiple studies have found that micronized progesterone carries a more favorable breast cancer risk profile than synthetic progestins. This is not a compounded vs. commercial distinction — it is a progesterone type distinction, and FDA-approved micronized progesterone (Prometrium) is available commercially.
Are compounded bioidentical hormones better than FDA-approved options?+
Not necessarily — and in some cases they carry additional risks. Compounded hormones are custom-mixed by a pharmacy and are not reviewed by the FDA for safety, efficacy, or quality control. Dosing can vary between batches. The Menopause Society explicitly advises that FDA-approved hormone therapy is preferred over compounded formulations for most patients, because the safety data on compounded hormones is limited. There are legitimate uses for compounding — non-standard delivery routes, specific dose adjustments, or cases where commercial options are unavailable — but the idea that compounded = safer is not supported by evidence.
What does BHRT mean in practice?+
BHRT stands for bioidentical hormone replacement therapy. In mainstream clinical settings it usually refers to FDA-approved bioidentical hormones like estradiol patches/gels and micronized progesterone. In some alternative medicine contexts, BHRT specifically means custom-compounded hormones, often with saliva testing as the basis for dosing — a practice the Menopause Society does not endorse, since saliva hormone levels do not accurately reflect circulating levels. When a provider says they offer BHRT, it is worth asking specifically: do you use FDA-approved options, compounded, or both?